152 related articles for article (PubMed ID: 35347801)
1. Dose-escalated simultaneously integrated boost radiation protocol fails to result in a survival advantage for sinonasal tumors in dogs.
Meier V; Staudinger C; Körner M; Soukup A; Rohrer Bley C
Vet Radiol Ultrasound; 2022 Sep; 63(5):633-648. PubMed ID: 35347801
[TBL] [Abstract][Full Text] [Related]
2. A prospective pilot study on early toxicity from a simultaneously integrated boost technique for canine sinonasal tumours using image-guided intensity-modulated radiation therapy.
Soukup A; Meier V; Pot S; Voelter K; Rohrer Bley C
Vet Comp Oncol; 2018 Dec; 16(4):441-449. PubMed ID: 29761663
[TBL] [Abstract][Full Text] [Related]
3. Using biologically based objectives to optimize boost intensity-modulated radiation therapy planning for brainstem tumors in dogs.
Meier V; Besserer J; Rohrer Bley C
Vet Radiol Ultrasound; 2020 Jan; 61(1):77-84. PubMed ID: 31600027
[TBL] [Abstract][Full Text] [Related]
4. Definitive-intent intensity modulated radiotherapy for modified-Adams' stage 4 canine sinonasal cancer: A retrospective study of 29 cases (2011-2017).
Stevens A; Turek M; Vail D; Christensen N; Forrest L
Vet Radiol Ultrasound; 2020 Nov; 61(6):718-725. PubMed ID: 32713101
[TBL] [Abstract][Full Text] [Related]
5. Outcome of intensity-modulated radiation therapy-based stereotactic radiation therapy for treatment of canine nasal carcinomas.
Fox-Alvarez S; Shiomitsu K; Lejeune AT; Szivek A; Kubicek L
Vet Radiol Ultrasound; 2020 May; 61(3):370-378. PubMed ID: 32189433
[TBL] [Abstract][Full Text] [Related]
6. Retrospective assessment of radiation toxicity from a definitive-intent, moderately hypofractionated image-guided intensity-modulated protocol for anal sac adenocarcinoma in dogs.
Körner M; Staudinger C; Meier V; Rohrer Bley C
Vet Comp Oncol; 2022 Mar; 20(1):8-19. PubMed ID: 33890343
[TBL] [Abstract][Full Text] [Related]
7. Definitive-intent intensity-modulated radiation therapy provides similar outcomes to those previously published for definitive-intent three-dimensional conformal radiation therapy in dogs with primary brain tumors: A multi-institutional retrospective study.
Van Asselt N; Christensen N; Meier V; Rohrer Bley C; Laliberte S; Poirier VJ; Desai N; Chen Y; Turek M
Vet Radiol Ultrasound; 2020 Jul; 61(4):481-489. PubMed ID: 32356907
[TBL] [Abstract][Full Text] [Related]
8. Outcome of a dog undergoing definitive-intent intensity-modulated radiation therapy for an intranasal ganglioneuroma.
Kitagawa K; Reich SN; Desai N; Policelli R; Zimmerman A; Sledge D; Vilar Saavedra P
Vet Radiol Ultrasound; 2020 Sep; 61(5):E50-E54. PubMed ID: 32542944
[TBL] [Abstract][Full Text] [Related]
9. Definitive-intent intensity-modulated radiation therapy for treatment of canine prostatic carcinoma: A multi-institutional retrospective study.
Walz JZ; Desai N; Van Asselt N; Poirier VJ; Hansen K; Selmic L
Vet Comp Oncol; 2020 Sep; 18(3):381-388. PubMed ID: 31811693
[TBL] [Abstract][Full Text] [Related]
10. Proof of principle of ocular sparing in dogs with sinonasal tumors treated with intensity-modulated radiation therapy.
Lawrence JA; Forrest LJ; Turek MM; Miller PE; Mackie TR; Jaradat HA; Vail DM; Dubielzig RR; Chappell R; Mehta MP
Vet Radiol Ultrasound; 2010; 51(5):561-70. PubMed ID: 20973393
[TBL] [Abstract][Full Text] [Related]
11. Can volumetric modulated arc radiation therapy reduce organ at risk dose in stage 4 sinonasal tumors in dogs treated with boost irradiation?
Meier V; Czichon F; Walsh L; Rohrer Bley C
PLoS One; 2021; 16(10):e0259112. PubMed ID: 34714825
[TBL] [Abstract][Full Text] [Related]
12. Ocular and periocular radiation toxicity in dogs treated for sinonasal tumors: A critical review.
Wolf F; Meier VS; Pot SA; Rohrer Bley C
Vet Ophthalmol; 2020 Jul; 23(4):596-610. PubMed ID: 32281234
[TBL] [Abstract][Full Text] [Related]
13. Clinical-dosimetric relationship between lacrimal gland dose and keratoconjunctivitis sicca in dogs with sinonasal tumors treated with radiation therapy.
Poirier VJ; Matsuyama A; Kim C; Darko J; Fleck A
J Vet Intern Med; 2020 Mar; 34(2):867-872. PubMed ID: 32086981
[TBL] [Abstract][Full Text] [Related]
14. Treatment of intracranial neoplasia in dogs using higher doses: A randomized controlled trial comparing a boosted to a conventional radiation protocol.
Staudinger C; Meier V; Beckmann K; Körner M; Rohrer Bley C
J Vet Intern Med; 2022 Jul; 36(4):1353-1364. PubMed ID: 35775129
[TBL] [Abstract][Full Text] [Related]
15. A complication probability study for a definitive-intent, moderately hypofractionated image-guided intensity-modulated radiotherapy protocol for anal sac adenocarcinoma in dogs.
Meier V; Besserer J; Roos M; Rohrer Bley C
Vet Comp Oncol; 2019 Mar; 17(1):21-31. PubMed ID: 30136336
[TBL] [Abstract][Full Text] [Related]
16. Proton spot scanning radiotherapy of spontaneous canine tumors.
Mayer-Stankeová S; Fidel J; Wergin MC; Hauser B; Sumová A; Goitein G; Pedroni E; Lomax AJ; Schneider U; Blattmann H; Kaser-Hotz B
Vet Radiol Ultrasound; 2009; 50(3):314-8. PubMed ID: 19507399
[TBL] [Abstract][Full Text] [Related]
17. Response and outcome following radiation therapy of macroscopic canine plasma cell tumours.
Elliott J; Looper J; Keyerleber M; Turek M; Blackwood L; Henry J; Gieger T
Vet Comp Oncol; 2020 Dec; 18(4):718-726. PubMed ID: 32419347
[TBL] [Abstract][Full Text] [Related]
18. Minimal late radiation toxicity and transient early toxicity following postoperative definitive intent conformal radiation therapy (20 × 2.5 Gy) for canine apocrine gland anal sac adenocarcinoma.
Williams C; Parys M; Handel I; Serra JC; Lawrence J
Vet Radiol Ultrasound; 2022 Mar; 63(2):224-233. PubMed ID: 34904326
[TBL] [Abstract][Full Text] [Related]
19. Relative tumor volume has prognostic relevance in canine sinonasal tumors treated with radiation therapy: A retrospective study.
Czichon F; Rohrer Bley C; Meier V
PLoS One; 2022; 17(5):e0269083. PubMed ID: 35622873
[TBL] [Abstract][Full Text] [Related]
20. A retrospective study of 101 dogs with oral melanoma treated with a weekly or biweekly 6 Gy × 6 radiotherapy protocol.
Baja AJ; Kelsey KL; Ruslander DM; Gieger TL; Nolan MW
Vet Comp Oncol; 2022 Sep; 20(3):623-631. PubMed ID: 35338766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
